Abera Bioscience AB (NGM:ABERA)
Sweden
· Delayed Price · Currency is SEK 5.90
-0.40 (-6.35%)
At close: Feb 27, 2025
Abera Bioscience AB Revenue
In the year 2024, Abera Bioscience AB had annual revenue of 14.85M SEK with 488.13% growth. Abera Bioscience AB had revenue of 4.72M in the quarter ending December 31, 2024, with 90.51% growth.
Revenue
14.85M
Revenue Growth
+488.13%
P/S Ratio
6.10
Revenue / Employee
2.47M
Employees
6
Market Cap
90.58M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Investor AB | 176.78B |
| Atlas Copco AB | 176.77B |
| AB Volvo | 526.82B |
| EQT AB | 30.40B |
| ASSA ABLOY AB | 150.16B |
| Skandinaviska Enskilda Banken AB | 81.00B |
| Hexagon AB | 61.89B |
| Telefonaktiebolaget LM Ericsson | 247.88B |